Research Appraisaldiagnostic

A hybrid BiLSTM and rule-based system for integrated diabetes prediction and personalized guidance

PloS oneSaleem, Muhammad, Hamid, Muhammad, Malik, SaadiaDOI

Clinical Snapshot

70CEBM
Evidence: Moderatediagnostic

PICO Framework

P — PopulationPatients at risk for or with diabetes mellitus type 2, using combined PIMA and Type 2 Diabetes datasets
I — InterventionHybrid BiLSTM and rule-based system for diabetes prediction and personalized lifestyle guidance
C — ComparatorSeven traditional machine learning models and standard deep learning models
O — OutcomesDiagnostic accuracy (84.02%), precision (87.89%), recall (80.50%), and personalized lifestyle recommendations

Bottom Line

This study presents a hybrid machine learning system combining BiLSTM prediction with rule-based guidance for diabetes management, achieving 84% diagnostic accuracy. While the technical performance is promising, the study lacks crucial clinical validation and real-world testing. The system shows potential for bridging the gap between diagnosis and patient self-management, but clinicians should await prospective clinical trials before considering implementation. The absence of external validation, cost-effectiveness data, and patient outcome measures limits immediate clinical applicability. Australian practitioners should consider local diabetes prevalence patterns and existing screening protocols when evaluating this technology's potential utility.

Evidence: Moderate

Key Findings

  • P Value: Not reported

  • Effect Size: 84.02% accuracy

  • Primary Outcome: Diagnostic accuracy for diabetes prediction

  • Nnt Or Sensitivity: Sensitivity (recall): 80.50%, Specificity: Not explicitly reported, Precision: 87.89%

  • Confidence Interval: Not reported

Clinical Application

Requires validation in clinical settings before implementation; integration with existing EMR systems needed Would need validation against Australian diabetes prevalence patterns; potential integration with RACGP diabetes screening guidelines and PBS diabetes management programs Adults at risk for type 2 diabetes requiring screening and lifestyle guidance

Abstract

Diabetes is a common chronic disease that needs early diagnosis and proper management to avoid severe complications. While current Artificial Intelligence (AI) tools generate predictive information, they often lack an integrated element for post-diagnosis support in order to fill in this critical gap in patient self-management. This research proposes and validates a hybrid System which aims to bridge this gap. The methodology is based on a novel, fused dataset (PIMA and Type 2 Diabetes) that was carefully preprocessed following a leakage-safe protocol in order to increase generalizability. The system architecture is a combination of two different critical components: Strong Bidirectional Long Short term Memory (BiLSTM) model for prediction and rule based engine for creating personalized lifestyle recommendations. In order to validate the efficacy of the BiLSTM model, seven traditional machine learning (ML) models and standard deep learning (DL) models have been comparatively tested, in which BiLSTM model has demonstrated a better generalization and prediction performance. Rigorous 10-fold cross validation was used to validate the system, which came up with an accuracy of 84.02%, precision of 87.89%, and recall of 80.50%. This research concludes that by successfully combining the high-performance predictive engine and real-time guidance module, it is possible to develop a holistic clinically relevant tool to close the loop between diagnosis and proactive self-management.

References

  1. 1.Saleem, M., Hamid, M., & Malik, S. (2026). A hybrid BiLSTM and rule-based system for integrated diabetes prediction and personalized guidance. PLoS One. https://doi.org/10.1016/j.heliyon.2024.e24536
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service